Common Contracts
3 similar Exchange Agreement contracts by Jaguar Health, Inc.
EXCHANGE AGREEMENTExchange Agreement • September 15th, 2026 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
This Exchange Agreement (this “Agreement”) is entered into as of July 7, 2026 (the “Effective Date”) by and between Streeterville Capital, LLC, a Utah limited liablity company (“Lender”), and Jaguar Health, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Royalty Interest (as defined below).
EXCHANGE AGREEMENTExchange Agreement • September 15th, 2026 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
This Exchange Agreement (this “Agreement”) is entered into as of September 14, 2026 (the “Effective Date”) by and between Streeterville Capital, LLC, a Utah limited liablity company (“Lender”), and Jaguar Health, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Royalty Interest (as defined below).
EXCHANGE AGREEMENTExchange Agreement • September 15th, 2026 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
This Exchange Agreement (this “Agreement”) is entered into as of September 11, 2026 (the “Effective Date”) by and between Streeterville Capital, LLC, a Utah limited liablity company (“Lender”), and Jaguar Health, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Royalty Interest (as defined below).